Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacy

Hepatology

Volumn 57, Issue 6, 2013, Pages 2448-2457

  Laleman, Wim ^a   Simon Talero, Macarena ^b   Maleux, Geert ^a   Perez, Mercedes ^b   Ameloot, Koen ^a   Soriano, German ^c   Villalba, Jordi ^d   Garcia Pagan, Juan Carlos ^e   Barrufet, Marta ^e   Jalan, Rajiv ^f   Brookes, Jocelyn ^f   Thalassinos, Evangelos ^g   Burroughs, Andrew K ^g   Cordoba, Juan ^b   Nevens, Frederik ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^g ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BACTERIAL PERITONITIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SELECTION; PORTAL VEIN THROMBOSIS; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECANALIZATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; SPONTANEOUS PORTOSYSTEMIC SHUNT;

ADULT; AGED; AGED, 80 AND OVER; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84879071149     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26314     Document Type: Article

References (34)

1. Cordoba J, Minguez B. Hepatic encephalopathy. Semin Liver Dis 2008; 28: 70-80.
2. Laleman W, Van Landeghem L, Wilmer A, Fevery J, Nevens F. Portal hypertension: from pathophysiology to clinical practice. Liver Int 2005; 25: 1079-1090.
3. Shawcross DL, Olde Damink SW, Butterworth RF, Jalan R. Ammonia and hepatic encephalopathy: the more things change, the more they remain the same. Metab Brain Dis 2005; 20: 169-179.
4. Cordoba J. New assesment of hepatic encephalopathy. J Hepatol 2011; 54: 1030-1040.
5. Witters P, Maleux G, George C, Delcroix M, Hoffman I, Gewillig M, et al. Congenital venovenous malformations of the liver: widely variable clinical presentations. J Gastroenterol Hepatol 2008; 23: 390-394.
6. Stepanova M, Mishra A, Venkatesan C, Younossi ZM. In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. Clin Gastroenterol Hepatol 2012; 10: 1034-1041.e1.
7. Lam KC, Juttner HU, Reynold TB. Spontaneous portosystemic shunt: relationship to spontaneous encephalopathy and gastrointestinal hemorrhage. Dig Dis Sci 1981; 26: 346-352.
8. Ohnishi K, Sato S, Saito M, Terabayashi H, Nakayama T, Saito M, et al. Clinical and hemodynamic features in cirrhotic patients having a large spontaneous splenorenal and/or gastrorenal shunt. Am J Gastroenterol 1986; 81: 450-455.
9. Riggio O, Efrati C, Catalano C, Pediconi F, Mecarelli O, Accornero N, et al. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case control study. HEPATOLOGY 2005; 42: 1158-1165.
10. Kato K, Kondo S, Hirano S, Omi M, Ambo Y, Okushiba S, et al. Surgical closure of the gastrorenal shunt with distal splenorenal shunt operation for portosystemic encephalopathy. Hepatogastroenterology 2001; 48: 840-841.
11. Henderson JM. Treatment portal systemic encephalopathy by embolization of the shunt. HEPATOLOGY 1989; 9: 164-165.
12. Zidi SH, Zanditenas D, Gelu-Simeon M, Rangheard AS, Valla DC, Vilgrain V, et al. Treatment of chronic portosystemic encephalopathy in cirrhotic patients by embolization of portosystemic shunts. Liver Int 2007; 27: 1389-1393.
13. Uflacker R, Silva Ade O, d'Albuquerque LA, Piske RL, Mourao GS. Chronic portosystemic encephalopathy: embolisation of portosystemic shunts. Radiology 1987; 165: 721-725.
14. Boixadera H, Tomasello H, Quiroga S, Cordoba J, Perez M, Segarra A. Succesful embolization of a spontaneous mesocaval shunt using the Amplatzer Vascular Plug II. Cardiovasc Interv Radiol 2010; 33: 1044-1048.
15. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001; 12: 327-336.
16. Caturelli E, Pompili M, Squillante MM, Sperandeo G, Carughi S, Sperandeo M, et al. Cruveilhier-Baumgarten syndrome: an efficient spontaneous portosystemic collateral preventing oesophageal varices bleeding. J Gastroenterol Hepatol 1994; 9: 236-241.
17. Hsieh JS, Wang JY, Huang CJ, Chen FM, Huang TJ. Effect of spontaneous portosystemic shunts on hemorrhage from esophagogastric varices. World J Surg 2004; 28: 23-28.
18. Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis 1978; 23: 398-406.
19. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna 1998. HEPATOLOGY 2002; 35: 716-721.
20. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54: 1044-1054.
21. Sarin SK. Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc 1997; 46: 8-14.
22. European Association for the Study of the Liver. EASL Clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.
23. Gines P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. HEPATOLOGY 1987; 7: 122-128.
24. Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol 2012; 107: 247-252.
25. Cordoba J, Garcia-Martinez R, Simon-Talero M. Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence. Metab Brain Dis 2010; 25: 73-80.
26. Morgan M, Blei A, Grüngreiff K, Jalan R, Kircheis G, Marchesine G, et al. The treatment of hepatic encephalopathy. Metab Brain Dis 2007; 22: 389-345.
27. Agrawal A, Sharma BC, Sharma P, Sarin SK. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Am J Gastroenterol 2012; 107: 1043-1050.
28. Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010; 362: 1071-1081.
29. Nevens F, Laleman W. Artificial liver support devices as treatment option for liver failure. Best Pract Res Clin Gastroenterol 2012; 26: 17-26.
30. Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch B, Mehta R, et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. HEPATOLOGY 2007; 46: 1853-1862.
31. Watanabe A. Portal-systemic encephalopathy in noncirrhotic patients: classification of clinical types, diagnosis and treatment. J Gastroenterol Hepatol 2000; 15: 969-979.
32. Maleux G, Heye S, Verslype C, Nevens F. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study. J Vasc Interv Radiol 2007; 18: 986-992.
33. Del Piccolo F, Sacerdoti D, Amodio P, Bombonato G, Bolognesi M, Mapelli D, et al. Central nervous system alterations in liver cirrhosis: the role of portal-systemic shunt and portal hypoperfusion. Metab Brain Dis 2002; 17: 347-358.
34. Takashi M, Igarashi M, Hino S, Takayasu K, Goto N, Musha H, et al. Portal hemodynamics in chronic portal-systemic encephalopathy. J Hepatol 1985; 1: 467-476.